Literature DB >> 2498257

Inhibitory action of transforming growth factor-beta on induction of differentiation of myeloid leukemia cells.

J Okabe-Kado1, Y Honma, M Hayashi, M Hozumi.   

Abstract

The effect of transforming growth factor-beta (TGF-beta) on induction of differentiation of mouse myeloid leukemia M1 cells was investigated. TGF-beta 1 induced adherence of M1 cells to plastic dishes and inhibited their proliferation. However, it did not induce differentiation-associated properties, such as phagocytic activity, lysozyme activity or morphological maturation. TGF-beta 1 also caused dose-dependent inhibition of dexamethasone-induced differentiation of M1 cells. The inhibitory activity of TGF-beta 1 was 20 times that of TGF-beta 2 on M1 cells. These results suggest that TGF-beta 1 inhibits proliferation and dexamethasone-induced differentiation of M1 cells by interacting with receptors that can distinguish between TGF-beta 1 and TGF-beta 2. TGF-beta 1 had a much lower inhibitory effect on the growth of a variant M1 cell clone, which was resistant to differentiation inducers, and it did not induce adherence of the resistant M1 cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2498257      PMCID: PMC5917715          DOI: 10.1111/j.1349-7006.1989.tb02297.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  14 in total

1.  The TGF-beta family of growth and differentiation factors.

Authors:  J Massagué
Journal:  Cell       Date:  1987-05-22       Impact factor: 41.582

2.  Antibodies to the N-terminal portion of cartilage-inducing factor A and transforming growth factor beta. Immunohistochemical localization and association with differentiating cells.

Authors:  L R Ellingsworth; J E Brennan; K Fok; D M Rosen; H Bentz; K A Piez; S M Seyedin
Journal:  J Biol Chem       Date:  1986-09-15       Impact factor: 5.157

3.  Type beta transforming growth factor is a potent inhibitor of murine megakaryocytopoiesis in vitro.

Authors:  T Ishibashi; S L Miller; S A Burstein
Journal:  Blood       Date:  1987-06       Impact factor: 22.113

4.  Characterization of a differentiation-inhibitory activity from nondifferentiating mouse myeloid leukemia cells.

Authors:  J Okabe-Kado; M Hayashi; Y Honma; M Hozumi
Journal:  Cancer Res       Date:  1985-10       Impact factor: 12.701

5.  Purification of a factor inhibiting differentiation from conditioned medium of nondifferentiating mouse myeloid leukemia cells.

Authors:  J Okabe-Kado; T Kasukabe; Y Honma; M Hayashi; M Hozumi
Journal:  J Biol Chem       Date:  1988-08-05       Impact factor: 5.157

6.  Transforming growth factor beta inhibits the proliferation of the blast cells of acute myeloblastic leukemia.

Authors:  N Tessier; T Hoang
Journal:  Blood       Date:  1988-07       Impact factor: 22.113

7.  Cell adhesion protein receptors as targets for transforming growth factor-beta action.

Authors:  R A Ignotz; J Massagué
Journal:  Cell       Date:  1987-10-23       Impact factor: 41.582

8.  Transforming growth factor-beta: biological function and chemical structure.

Authors:  M B Sporn; A B Roberts; L M Wakefield; R K Assoian
Journal:  Science       Date:  1986-08-01       Impact factor: 47.728

9.  Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells.

Authors:  T Masui; L M Wakefield; J F Lechner; M A LaVeck; M B Sporn; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

10.  Transforming growth factor beta 1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell lines.

Authors:  J R Keller; C Mantel; G K Sing; L R Ellingsworth; S K Ruscetti; F W Ruscetti
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

View more
  1 in total

1.  Transforming growth factor-beta regulates human retinal pigment epithelial cell phagocytosis by influencing a protein kinase C-dependent pathway.

Authors:  S J Sheu; T Sakamoto; R Osusky; H M Wang; T E Ogden; S J Ryan; D R Hinton; R Gopalakrishna
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-11       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.